Effects of Alanyl-Glutamine Treatment on the Peritoneal Dialysis Effluent Proteome Reveal Pathomechanism-Associated Molecular Signatures

Peritoneal dialysis (PD) is a modality of renal replacement therapy in which the high volumes of available PD effluent (PDE) represents a rich source of biomarkers for monitoring disease and therapy. Although this information could help guide the management of PD patients, little is known about the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cell Proteomics
Autors principals: Herzog, Rebecca, Boehm, Michael, Unterwurzacher, Markus, Wagner, Anja, Parapatics, Katja, Májek, Peter, Mueller, André C., Lichtenauer, Anton, Bennett, Keiryn L., Alper, Seth L., Vychytil, Andreas, Aufricht, Christoph, Kratochwill, Klaus
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Biochemistry and Molecular Biology 2018
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5836375/
https://ncbi.nlm.nih.gov/pubmed/29208752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.RA117.000186
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars